Its not a matter of willpower
One is part of Lillys broader development plan but wont read out for years
Reduced calorie intake, dehydration, digestive symptoms, sleep changes, blood-sugar changes, and other medical conditions may contribute
Tirzepatide is unique as it is a dual GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptor agonist, which means it targets two natural incretin hormones, offering potentially even greater benefits for blood sugar control and weight reduction
See also the letter Archived 2008-07-24 at the Wayback MachineJAMA by Philip Taylor and Sanford Dawsey and the reply Archived 2008-06-24 at the Wayback Machine "Oxygen Radical Absorbance Capacity (ORAC) of Selected Foods, Release 2 (2010)"
However, both medications can cause gastrointestinal effectsmetformin commonly causes diarrhea, bloating, and nausea in the first weeks of treatment, while semaglutide typically causes mild nausea and can reduce appetite